Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microenvironmental interactions in classical Hodgkin lymphoma and their role in promoting tumor growth, immune escape and drug resistance
Donatella Aldinucci, Marta Celegato, Naike Casagrande
Cancer Letters (2015) Vol. 380, Iss. 1, pp. 243-252
Closed Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

Exosomal circRNAs: biogenesis, effect and application in human diseases
Yangxia Wang, Jinbo Liu, Junfen Ma, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 540
Preferential Cancer Cell Self-Recognition and Tumor Self-Targeting by Coating Nanoparticles with Homotypic Cancer Cell Membranes
Jingyi Zhu, Diwei Zheng, Ming‐Kang Zhang, et al.
Nano Letters (2016) Vol. 16, Iss. 9, pp. 5895-5901
Closed Access | Times Cited: 422
Epstein–Barr virus-associated lymphomas
Claire Shannon‐Lowe, Alan B. Rickinson, Andrew Bell
Philosophical Transactions of the Royal Society B Biological Sciences (2017) Vol. 372, Iss. 1732, pp. 20160271-20160271
Open Access | Times Cited: 383
Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs
Li Qiao, Shiqi Hu, Ke Huang, et al.
Theranostics (2020) Vol. 10, Iss. 8, pp. 3474-3487
Open Access | Times Cited: 316
The CCL5/CCR5 Axis in Cancer Progression
Donatella Aldinucci, Cinzia Borghese, Naike Casagrande
Cancers (2020) Vol. 12, Iss. 7, pp. 1765-1765
Open Access | Times Cited: 305
Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer
Donatella Aldinucci, Naike Casagrande
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 5, pp. 1477-1477
Open Access | Times Cited: 125
CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth
Naike Casagrande, Cinzia Borghese, Lydia Visser, et al.
Haematologica (2018) Vol. 104, Iss. 3, pp. 564-575
Open Access | Times Cited: 76
Hodgkin Lymphoma-Derived Extracellular Vesicles Change the Secretome of Fibroblasts Toward a CAF Phenotype
Bastian Dörsam, Teresa Bösl, Katrin S. Reiners, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 64
miR-1266 Contributes to Pancreatic Cancer Progression and Chemoresistance by the STAT3 and NF-κB Signaling Pathways
Xin Zhang, Dong Ren, Xianqiu Wu, et al.
Molecular Therapy — Nucleic Acids (2018) Vol. 11, pp. 142-158
Open Access | Times Cited: 54
A phase II study of the oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma
Éric Van Den Neste, Marc André, Thomas Gastinne, et al.
Haematologica (2018) Vol. 103, Iss. 5, pp. 840-848
Open Access | Times Cited: 53
Brentuximab vedotin: clinical updates and practical guidance
Jun Ho Yi, Seok Jin Kim, Won Seog Kim
Blood Research (2017) Vol. 52, Iss. 4, pp. 243-243
Open Access | Times Cited: 52
Formation of the Immunosuppressive Microenvironment of Classic Hodgkin Lymphoma and Therapeutic Approaches to Counter It
Donatella Aldinucci, Cinzia Borghese, Naike Casagrande
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 10, pp. 2416-2416
Open Access | Times Cited: 51
CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with Brentuximab-Vedotin,in vitro
Hinrich P. Hansen, Ahmad Trad, Maria Dams, et al.
Oncotarget (2016) Vol. 7, Iss. 21, pp. 30523-30535
Open Access | Times Cited: 48
The Hodgkin Lymphoma Immune Microenvironment: Turning Bad News into Good
Victoria Menéndez, José Luis Solórzano, Sara Monzón, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1360-1360
Open Access | Times Cited: 26
Immune and Inflammatory Cells of the Tumor Microenvironment Represent Novel Therapeutic Targets in Classical Hodgkin Lymphoma
Eleonora Calabretta, Francesco d’Amore, Carmelo Carlo‐Stella
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 21, pp. 5503-5503
Open Access | Times Cited: 43
Downregulation of miR-374b-5p promotes chemotherapeutic resistance in pancreatic cancer by upregulating multiple anti-apoptotic proteins
Di Sun, Xu Wang, Guoqing Sui, et al.
International Journal of Oncology (2018)
Open Access | Times Cited: 40
Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin Lymphoma
Kristiina Karihtala, Suvi‐Katri Leivonen, Oscar Brück, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 877-877
Open Access | Times Cited: 38
Macrophages and angiogenesis in human lymphomas
Doménico Ribatti, Roberto Tamma, Tiziana Annese, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Immunosenescence and lymphomagenesis
Salvatrice Mancuso, Melania Carlisi, Marco Santoro, et al.
Immunity & Ageing (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 38
Lymphomas and Their Microenvironment: A Multifaceted Relationship
Thomas Menter, Alexandar Tzankov
Pathobiology (2019) Vol. 86, Iss. 5-6, pp. 225-236
Open Access | Times Cited: 30
Trabectedin overcomes doxorubicin-resistance, counteracts tumor-immunosuppressive reprogramming of monocytes and decreases xenograft growth in Hodgkin lymphoma
Naike Casagrande, Cinzia Borghese, Andrea Favero, et al.
Cancer Letters (2020) Vol. 500, pp. 182-193
Closed Access | Times Cited: 30
Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma
Alex Reza Gholiha, Peter Hollander, Ingrid Glimelius, et al.
Blood Advances (2021) Vol. 5, Iss. 6, pp. 1671-1681
Open Access | Times Cited: 26
Immunosuppressive Microenvironment and Efficacy of PD-1 Inhibitors in Relapsed/Refractory Classic Hodgkin Lymphoma: Checkpoint Molecules Landscape and Macrophage Populations
Artem Gusak, Liudmila Fedorova, Kirill V. Lepik, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5676-5676
Open Access | Times Cited: 24
Drug Resistance: The Role of Exosomal miRNA in the Microenvironment of Hematopoietic Tumors
Mariaconcetta Cariello, Angela Squilla, Martina Piacente, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 116-116
Open Access | Times Cited: 17
In Vitro 3D Models of Haematological Malignancies: Current Trends and the Road Ahead?
Carlotta Mattioda, Claudia Voena, Gianluca Ciardelli, et al.
Cells (2025) Vol. 14, Iss. 1, pp. 38-38
Open Access
Page 1 - Next Page

Scroll to top